Announced Fri, 10 Jul · 15:24 IST
Bacil Pharma: Rights Issue of up to Rs 50 Cr, two independent directors resign
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.2%1-day move
₹38.36
prior close
₹38.01
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.2-2.2-3.9-3.8-4.8-14.3————
Up moveDown movePending
AI summary
Bacil Pharma's board approved a Rights Issue of equity shares up to Rs 50 Crores and an Authorised Share Capital hike of Rs 45 Crores (post-increase Rs 65 Crores). Two Independent Directors, Mr. Dinesh Chander Notiyal and Ms. Avani Savjibhai Godhaniya, resigned effective 9 July 2026 due to time constraints. Axis Bank, Purva Sharegistry, and Acuite Ratings were appointed as intermediaries for the issue.
Likely market impact
Shareholders face potential dilution from a Rs 50 Crore Rights Issue; board loses two independent directors with no replacements named yet.